Skip to main content

Table 2 Key documents in the CDR process

From: Patients’ perspectives can be integrated in health technology assessments: an exploratory analysis of CADTH Common Drug Review

Summary of Patient Input

For each assessment, two CADTH reviewers consolidate and summarize information submitted via the patient input templates from all contributing patient groups. Contributing patient groups are asked to validate the summaries produced by CADTH to ensure all insights have been accurately captured. These summaries are included in the assessment reports.

CDR Assessment Protocol

The protocol is developed by a CADTH review team that includes three CADTH clinical reviewers, two health economists, a methodologist, and two external clinical specialists. The protocol follows the population, intervention, comparison, outcome (PICO) format.

CDR Assessment Report

CADTH reviewers analyze, appraise, and summarize all relevant trial data submitted to CADTH for the review. The trial design and outcome selection decisions rest with the pharmaceutical company and other external trial sponsors. A review of the assessment report allowed us to determine the extent to which patient insights were addressed in clinical trials performed by others.

CDEC Recommendation

This publicly available document describes the recommendation resulting from CDEC deliberations and the reasons for that recommendation. While it does not capture the full discussion, it provides a record of the considerations CDEC has agreed to highlight. CDEC Recommendations were analyzed to ascertain the extent to which patient insights were incorporated into the CDEC deliberation.

  1. CDEC CADTH Canadian Drug Expert Committee, CDR CADTH Common Drug Review